References
- 1. Morris C, Pardo-Villamizar C, Gause C, Singer H. Serum autoantibodies measured by immunofluorescence confirm a failure to differentiate PANDAS and Tourette syndrome from controls. J Neurol Sci. 2009; 276(1-2): 45-48.
- 2. Hirschtritt ME, Hammond CJ, Luckenbaugh D, Buhle J, Thurm AE, Casey BJ, et al. Executive and attention functioning among children in the PANDAS subgroup. Child Neuropsychol. 2008; 11(2): 1-16.
- 3. Derenne JL. Abrupt-onset obsessive-compulsive disorder (OCD) in a child with Crohn’s disease. Psycho-somatics. 2009; 50(4): 425-426.
- 4. Snider L, Swedo S. Childhood-onset obsessivecompulsive disorder and tic disorders: case report and literature review. J Child Adolesc Psychopharmacol. 2003; 13(1): 81-88.
- 5. Gause C, Morris C, Vernekar S, Pardo-Villamizar C, Grados M, Singer H. Antineuronal antibodies in OCD: comparisons in children with OCDonly, OCD+chronic tics and OCD+PANDAS. J Neuroimmunol. 2009; 214(1-2): 118-124.
- 6. Maranta A, Stollerman GH. The relationship of Sydenham’s chorea to infection with group A streptococci. Am J Med. 1956; 20(2): 170-175.
- 7. Swedo SE, Rapoport JL, Cheslow DL, Leonard HL, Ayoub EM, Hosier DM, et al. High prevalence of obses-sive-compulsive symptoms in patients with Sydenham’s Chorea. Am J Psychiatry. 1989; 146(2): 246-249.
- 8. Rocha F, Correa H, Teixeira AL. Obsessivecompulsive disorder and immunology: a review. Neuropsy-chopharmacol Biol Psychiatry. 2008; 32(5): 1139-1146.
- 9. Swedo SE, Leonard HL, Rapoport JL. The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) subgroup: separating fact from fiction. Pediatrics. 2004; 113(4): 907-911.
- 10. Lewin A, Storch E, Geffken G, Goodman W, Murphy T. A neuropsychiatric review of pediatric obsessive-compulsive disorder: etiology and efficacious treatments. Neuropsychiatric Dis Treatment. 2006; 2(1): 21-31.
- 11. Morer A, Viñas O, Lázaro L, Calvo R, Andres S, Bosch J, et al. Subtyping obsessivecompulsive disorder: clinical and immunological findings in child and adult onset. J Psychiatric Res. 2006; 40(3): 207-213.
- 12. Irak M, Flament M. Neuropsychological profile of childhood-onset obsessivecompulsive disorder. Turk Psikiyatri Derg. 2007; 18(4): 293-301.
- 13. Karamustafalıoğlu O, Akpınar A. Obsesif kompulsif bozukluk. Turkiye Klinikleri J Int Med Sci. 2006; 2(12): 30-44.
- 14. Walitza S, Wendland JR, Gruenblatt E, Warnke A, Sontag TA, Tucha O, et al. Genetics of earlyonset obses-sive-compulsive disorder. Eur Child Adolesc Psychiatry. 2010; 19(3): 227-235.
- 15. Lochner C, Stein DJ. Gender in obsessivecompulsive disorder and obsessive-compulsive spectrum disorders. Arch Womens Ment Health. 2001; 4(1): 19-26.
- 16. Kim SW, Grant JE, Kim SI, Swanson TA, Bernstein GA, Jaszcz WB, et al. A possible association of recurrent streptococcal infections and acute onset of obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci. 2004; 16(3): 252-260.
- 17. Hoekstra PJ, Minderaa RB. Tic disorders and obsessive-compulsive disorder: is autoimmunity involved? Int Rev Psychiatry. 2005;17(6): 497-502.
- 18. Moretti G, Pasquini M, Mandarelli G, Tarsitani L, Biondi M. What every psychiatrist should know about PANDAS: a review. Clin Pract Epidemol Ment Health. 2008; 21(4): 13
- 19. Dale RC. Autoimmunity and the basal ganglia: new insights into old diseases. QJM. 2003; 96(3): 183-191.
- 20. Shulman ST. Pediatric autoimmune neuropsychiatric disorders associated with streptococci (PANDAS): update. Curr Opin Pediatr. 2009; 21(1): 127-130.
- 21. Dale RC, Heyman I, Giovannoni G, Church AW. Incidence of antibrain antibodies in children with obses-sive-compulsive disorder. Br J Psychiatry. 2005; 187(3): 314-319.
- 22. Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry. 1998; 155(2): 264-271.
- 23. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16(3): 1215.
- 24. Ramasawmy R, Faé KC, Spina G, Victora GD, Tanaka AC, Palácios SA, et al. Association of polymor-phisms within the promoter region of the tumor necrosis factor-α with clinical outcomes of rheumatic fever. Mol Immunol. 2007; 44(8): 1873-1878.
- 25. Pazarbaşı A, Kasap M, Güzel Aİ, Kasap H, Onbaşıoğlu M, Özbakır B. Polymorphisms in the tumor necrosis factor-α gene in Turkish women with pre-eclampsia and eclampsia. Acta Medica Okayama. 2007; 61(3): 153-160.
- 26. Kato T, Honda M, Kuwata S, Jujı T, Kunugı H, Nanko S, et al. Novel polymorphism in the promoter region of the tumor necrosis factor α gene: no association with narcolepsy. Am J Med Genet. 1999; 88(4): 301-304.
- 27. Kara A. Tonsillopharyngitis. J Pediatr Inf. 2009; 3(Suppl 1): 25-34.
- 28. Hounie AG, Cappi C, Cordeiro Q, Sampaio AS, Moraes I, Rosário MC, et al. TNF-α polymorphisms are associated with obsessive-compulsive disorder. Neurosci Lett. 2008; 442(2): 86-90.
- 29. Cardona F, Orefici G. Group A streptococcal infections and tic disorders in an Italian pediatric population. J Pediatr. 2001; 138(1): 71-75.
- 30. Leonard HL, Swedo SE. Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS). Int J Neuropsychopharmacol. 2001; 4(2): 191-198.